Klinische onderzoeken
BIOTRONIK is toegewijd aan het ondersteunen van verdere ontwikkelingen in de cardiologie en is zeer nauw betrokken geweest bij het uitvoeren van klinische onderzoeken. Onze wetenschappelijke activiteiten omvatten een verscheidenheid aan onderwerpen op het gebied van hartritmemanagement en cardiovasculaire interventie. In samenwerking met internationale medische experts streven wij ernaar de diagnose en behandeling van hart- en vaataandoeningen voortdurend te verbeteren.
De onderstaande databases bieden een overzicht van de onderzoeken van BIOTRONIK op het gebied van hartritmemanagement en cardiovasculaire interventie, naast gerelateerde publicaties en bronnen.
Filter Clinical Studies
4EVER
Physician-initiated trial investigating the safety of the full 4F endovascular treatment approach of infra-inguinal arterial stenotic disease
At-Home
Remote Management of Pacemaker Patients with Biennial In-clinic evaluation: Continuous Home Monitoring in the Japanese at Home Study. A Randomized Clinical Trial
Watanabe E ET AL., CIRCEP 2020 May;13(5):e007734
doi: 10.1161/CIRCEP.119.007734
BERN
Evaluate long segment (> 120 mm) complex femoro-popliteal disease with Pulsar stent stratified for Critical Limb Ischaemia vs. Intermittent Claudication
BIO-RESORT
Comparison of biodegradable polymer and durable polymer drug-eluting stents in an all comers population
BIO4AMB
Comparing the use of 4F- versus 6F-compatible devices for ambulatory peripheral vascular interventions
BIOFLEX PEACE
Evaluating the safety and efficacy of the Pulsar-18 self-expanding stent for femoropopliteal lesions with optional drug-coated balloon angioplasty in a real-world, all-comers population
BIOFLEX-COF
Investigating the influence of high versus low chronic outward force self-expanding nitinol stents in femoropopliteal occlusive arterial lesions
BIOFLEX-I
Prospective, international, multi-center, investigational device exemption trial evaluating BIOTRONIK Astron nitinol self-expanding stent for iliac arteries
BIOFLOW-I
First-in-man experience with a drug-eluting stent in de novo coronary artery lesions
BIOFLOW-II
Study of the Orsiro Drug Eluting Stent System
BIOFLOW-III
Investigating Orsiro drug-eluting coronary stent
BIOFLOW-V
Randomized Clinical Trial Comparing Orsiro1 Drug-Eluting Stent with Xience2 DES
BIOLUX 4EVER
Evaluating outcomes after treating stenotic or occluded femoropopliteal lesions with the Passeo-18 Lux DCB followed by Pulsar-18 BMS
BIOLUX AV
Assessing the safety and efficacy of paclitaxel-eluting balloon angioplasty for dysfunctional hemodialysis access
BIOLUX P-I
Clinical trial to assess the safety and performance of the coated Passeo-18 Lux paclitaxel-releasing PTA balloon catheter versus the uncoated Passeo-18 balloon catheter for treatment of stenosis of the femoropopliteal arteries
BIOLUX P-I/P-II/P-III Safety Analysis
To collect long-term clinical data on patients treated with either Passeo-18 PTA or Passeo-18 Lux DCB
BIOLUX P-II
First-in-human study to assess the safety and performance of the Passeo-18 Lux drug-coated balloon vs. the uncoated Passeo-18 balloon catheter in patients with stenosis and occlusion of the infrapopliteal arteries
BIOLUX P-III
Investigating safety and efficacy of Passeo-18 Lux in an all-comers real-world population with up to Rutherford 6 disease in the infrainguinal arteries
BIOLUX P-III BENELUX
Investigating the safety and efficacy of Passeo-18 Lux DCB for the treatment of isolated popliteal artery lesions
BIOLUX P-IV CHN
Investigating the safety and efficacy of Passeo-18 Lux DCB for the treatment of isolated popliteal artery lesions
BIOMAG-I
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study
BIOMONITOR III Pooled Analysis
New Generation Miniaturized Insertable Cardiac Monitor with a Long Sensing Vector: Insertion Procedure, Sensing Performance, and Home Monitoring Transmission Success in a Real-World Population
Deneke T et al., Heart Rhythm O2, 2022
BIONETIC-I
Evaluating safety and effectiveness of Dynetic-35 balloon-expandable stent for the treatment of atherosclerotic disease in the iliac arteries
BIONETIC-I TRA
Evaluating the safety and feasibility of using the Dynetic-35 stent via a transradial approach to treat iliac artery lesions